Trihale 200 Rotacap
Rx- Company:
- The ACME Laboratories Ltd.
- Pack size:
- Box (10 Capsule)
Save to my medicines
Alert me on price drop
৳ 90/unit
Pack: ৳ 900
At a glance
Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) and the maintenance treatment of asthma in patients aged 18 years and older.
Indications
- Chronic obstructive pulmonary disease (COPD)
- Asthma (18 years and older)
Dosage
Adult Dose (Inhalation):
- COPD maintenance: 1 inhalation capsule once daily
- Asthma maintenance: 1 inhalation capsule once daily
- Use at the same time every day, not more than once every 24 hours
Side effects
Common Side Effects:
- Upper respiratory tract infection
- Pneumonia
- Bronchitis
- Oral candidiasis
- Headache
- Back pain
- Arthralgia
- Influenza
- Sinusitis
- Pharyngitis
- Rhinitis
- Dysgeusia
- Constipation
- Urinary tract infection
- Diarrhea
- Gastroenteritis
- Oropharyngeal pain
- Cough
- Dysphonia
Precautions & warnings
- LABA monotherapy increases risk of serious asthma-related events
- Do not initiate in acutely deteriorating COPD or asthma
- Do not use to treat acute symptoms
- Do not use in combination with additional LABA-containing therapy
- Candida albicans infection of mouth and pharynx may occur; monitor periodically
- Increased risk of pneumonia in patients with COPD; monitor for signs and symptoms
- If paradoxical bronchospasm occurs, discontinue and institute alternative therapy
- Use with caution in patients with cardiovascular disorders
- Worsening of urinary retention may occur; caution in prostatic hyperplasia or bladder-neck obstruction
- Use with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, and ketoacidosis
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.